Artificial intelligence (AI) has been identified as a transformational influence on drug development.

Artificial Intelligence in pharma refers to the system of

interconnected and automated technologies in the biotech
industry which can function autonomously, with little or no
human intervention. AI is an emerging technology that is
finding its way into many facets of the pharma sector, from
drug development to diagnosis and even patient care.

Manufacturing improvements
AI in marketing
Artificial intelligence in Pharma refers to the use of automated
algorithms to perform tasks which traditionally rely on human
intelligence. Over the last five years, the use of artificial
intelligence in the pharma and biotech industry has redefined how
scientists develop new drugs, tackle disease, and more.
According to a recent report, big data and machine learning could profoundly influence the health care
system and potentially result in a market that generates $100 billion in annual sales.

Over the last five years, the applications of artificial intelligence in the drug industry has redefined how
scientists develop new drugs, tackle the disease, and more.